Stay updated on Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (v3.5.4) was added to the record history, indicating a minor update to the page's metadata/versioning. This does not modify the study data or visible content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new site revision tag 'Revision: v3.5.0' and removed the previous 'Revision: v3.4.3'. The update is a routine version change that does not affect study data or trial details.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed in the page history.SummaryDifference0.1%

- Check98 days agoChange DetectedLatest version adds a Study Status entry dated 2026-02-10 and records revision v3.4.2. It also removes a government funding notice from the page.SummaryDifference0.8%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.